Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Joseph Brown is active.

Publication


Featured researches published by Joseph Brown.


Annals of the New York Academy of Sciences | 1994

The type A/type B distinction. Subtyping alcoholics according to indicators of vulnerability and severity.

Joseph Brown; Thomas F. Babor; Mark D. Litt; Henry R. Kranzler

Multidimensional typologies of alcoholics are reviewed, including Cloningers neurobiological learning model, Morey and Skinners hybrid model, and Zuckers developmental model. The more recent Type A/Type B typology proposed by Babor and colleagues is reviewed in more depth, as is a previous replication and extension by Litt and colleagues. Both the original study and the replication indicate this typology is a useful tool in classifying alcoholic inpatients into two groups and in matching alcoholics to the most suitable treatment. The present study replicates the typology using outpatient samples of male alcoholics. The resulting two clusters are very similar to those identified by the two earlier studies. As expected, the relative proportion of Type A alcoholics is higher in the outpatient samples than in the previously studied inpatient samples. Preliminary analysis of the typologys clinical efficiency suggests that the variables used to classify subjects might be appreciably reduced, thus effecting a considerable time savings in assessment. A discriminant function analysis indicates that using only 5 of the original 16 clustering variables results in a correct classification rate of almost 95%. Future research directions are addressed.


Journal of Substance Abuse Treatment | 1993

Adverse effects limit the usefulness of fluvoxamine for the treatment of alcoholism

Henry R. Kranzler; Frances K. Del Boca; Patricia Korner; Joseph Brown

Open-label and placebo-controlled trials of fluvoxamine, a selective, serotonergic antidepressant, were conducted as an adjunct to relapse prevention psychotherapy in alcoholics. In the open trial, 16 inpatient alcoholics began a 12-week treatment program, with 10 patients dropping out during the first 4 weeks of treatment. In the controlled trial, 8 of 10 patients on fluvoxamine dropped out during the first 4 weeks of treatment, compared with only 1 of 9 patients on placebo. Baseline patient characteristics did not appear to explain the differential attrition in the controlled trial, although the placebo-treated patients were more alcohol dependent. In both trials, patients on fluvoxamine complained of a variety of adverse effects, which they often identified as the basis for early termination of treatment. These adverse effects appear to limit the usefulness of the medication for the treatment of alcoholism.


Psychosomatics | 1992

The Power of Statistical Studies in Consultation-Liaison Psychiatry

Joseph Brown; Mahlon S. Hale

Several authors recently have proclaimed the need for empirically based research articles in consultation-liaison psychiatry. The authors report that although the proportion of empirically based studies published in Psychosomatics increased 148% from 1979 to 1989, the power of statistical analyses and the deleterious effect of multiple tests were often neglected. A power analysis of empirical studies published in the 1989 volume year of Psychosomatics is reported, showing statistical power to be low for all but the most robust of effect sizes.


American Journal of Psychiatry | 1995

Placebo-controlled trial of fluoxetine as an adjunct to relapse prevention in alcoholics.

Henry R. Kranzler; Joseph A. Burleson; Patricia Korner; Del Boca Fk; Michael J. Bohn; Joseph Brown; Liebowitz N


Archives of General Psychiatry | 1994

Buspirone Treatment of Anxious Alcoholics: A Placebo-Controlled Trial

Henry R. Kranzler; Joseph A. Burleson; Frances K. Del Boca; Thomas F. Babor; Patricia Korner; Joseph Brown; Michael J. Bohn


Alcoholism: Clinical and Experimental Research | 1996

Fluoxetine treatment seems to reduce the beneficial effects of cognitive-behavioral therapy in type B alcoholics

Henry R. Kranzler; Joseph A. Burleson; Joseph Brown; Thomas F. Babor


Addiction | 1992

Self-reports by alcohol and drug abuse inpatients: factors affecting reliability and validity.

Joseph Brown; Henry R. Kranzler; Frances K. Del Boca


Alcoholism: Clinical and Experimental Research | 1996

Assessment of Medication Compliance in Alcoholics through UV Light Detection of a Riboflavin Tracer

Frances K. Del Boca; Henry R. Kranzler; Joseph Brown; Patricia Korner


Journal of Bacteriology | 1963

FATTY ACID COMPOSITION OF LIPIDS FROM STREPTOCOCCUS CREMORIS AND STREPTOCOCCUS LACTIS VAR. MALTIGENES

Patricia MacLeod; Joseph Brown


Alcoholism: Clinical and Experimental Research | 1982

Variation in alcoholism treatment orientation: Differential impact upon specific subpopulations

Joseph P. Lyons; John W. Welte; Joseph Brown; Lloyd Sokolow; Gerard Hynes

Collaboration


Dive into the Joseph Brown's collaboration.

Top Co-Authors

Avatar

Henry R. Kranzler

University of Pennsylvania

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Patricia Korner

University of Connecticut Health Center

View shared research outputs
Top Co-Authors

Avatar

Thomas F. Babor

University of Connecticut

View shared research outputs
Top Co-Authors

Avatar

Joseph A. Burleson

University of Connecticut Health Center

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Michael J. Bohn

University of Wisconsin-Madison

View shared research outputs
Top Co-Authors

Avatar

J. Thomas Rayne

United States Department of Veterans Affairs

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Mahlon S. Hale

University of Connecticut

View shared research outputs
Researchain Logo
Decentralizing Knowledge